Delivery Order SPE2DB20D1100-SPE2DB24FA2F2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of 4,564,360,652 units of the medication Carvedilol ER 40 mg capsules in packages of 30. The award, valued at $4,925.38, is a delivery order with a firm fixed price and an ultimate completion date of April 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,280.47, is for the delivery of 4,567,956,736 units of the medication Carvedilol ER 40 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 18, 2025. This award is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $4,369.30 and is structured as a firm fixed-price delivery order, with a period of performance ending on March 11, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 20 mg capsules. The $17,626.91 firm fixed-price contract has a completion date of June 1, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,315.69, is a Firm Fixed Price Delivery Order for the supply of Carvedilol ER 40 mg capsules. The award has an ultimate completion date of January 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The $10,734.40 firm fixed-price contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The $5,462.08 firm-fixed-price delivery order contract has an ultimate completion date of December 7, 2023. The award is not designated under any set-aside program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.28 delivery order contract is for the supply of 4,567,916,245 units of the prescription medication Carvedilol ER 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
- This federal contract award, valued at $5,063.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Carvedilol ER 40 mg capsules, a medication used to treat heart conditions. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) to supply 4,564,287,030 units of the medication Carvedilol ER 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $7,920.58 and a period of performance through April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA2F2Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (also known as AmerisourceBergen), a for-profit organization. The contract is for the delivery of 4,563,650,994 units of the pharmaceutical product Carvedilol ER 40 mg Capsule 30s. The contract is a firm fixed price delivery order with a potential value of $4,047.25 and a completion date of February 14, 2024. This award is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 2/13/24 |